Suppr超能文献

用于加速安全报告的临床试验电子门户:临床试验转型倡议研究性新药安全推进项目的建议

Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project.

作者信息

Perez Raymond P, Finnigan Shanda, Patel Krupa, Whitney Shanell, Forrest Annemarie

机构信息

The University of Kansas Cancer Center, Kansas City, KS, United States.

National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

出版信息

JMIR Cancer. 2016 Dec 15;2(2):e16. doi: 10.2196/cancer.6701.

Abstract

BACKGROUND

Use of electronic clinical trial portals has increased in recent years to assist with sponsor-investigator communication, safety reporting, and clinical trial management. Electronic portals can help reduce time and costs associated with processing paperwork and add security measures; however, there is a lack of information on clinical trial investigative staff's perceived challenges and benefits of using portals.

OBJECTIVE

The Clinical Trials Transformation Initiative (CTTI) sought to (1) identify challenges to investigator receipt and management of investigational new drug (IND) safety reports at oncologic investigative sites and coordinating centers and (2) facilitate adoption of best practices for communicating and managing IND safety reports using electronic portals.

METHODS

CTTI, a public-private partnership to improve the conduct of clinical trials, distributed surveys and conducted interviews in an opinion-gathering effort to record investigator and research staff views on electronic portals in the context of the new safety reporting requirements described in the US Food and Drug Administration's final rule (Code of Federal Regulations Title 21 Section 312). The project focused on receipt, management, and review of safety reports as opposed to the reporting of adverse events.

RESULTS

The top challenge investigators and staff identified in using individual sponsor portals was remembering several complex individual passwords to access each site. Also, certain tasks are time-consuming (eg, downloading reports) due to slow sites or difficulties associated with particular operating systems or software. To improve user experiences, respondents suggested that portals function independently of browsers and operating systems, have intuitive interfaces with easy navigation, and incorporate additional features that would allow users to filter, search, and batch safety reports.

CONCLUSIONS

Results indicate that an ideal system for sharing expedited IND safety information is through a central portal used by all sponsors. Until this is feasible, electronic reporting portals should at least have consistent functionality. CTTI has issued recommendations to improve the quality and use of electronic portals.

摘要

背景

近年来,电子临床试验门户的使用有所增加,以协助申办方与研究者之间的沟通、安全报告和临床试验管理。电子门户有助于减少与处理文书工作相关的时间和成本,并增加安全措施;然而,关于临床试验研究人员对使用门户所感知到的挑战和益处的信息却很缺乏。

目的

临床试验转化倡议(CTTI)旨在(1)确定肿瘤研究站点和协调中心的研究者接收和管理研究性新药(IND)安全报告的挑战,以及(2)促进采用使用电子门户来沟通和管理IND安全报告的最佳实践。

方法

CTTI是一个改善临床试验开展情况的公私合作项目,它通过分发调查问卷和进行访谈来收集意见,以记录研究者和研究人员在美国食品药品监督管理局最终规则(联邦法规汇编第21编第312节)所描述的新安全报告要求背景下对电子门户的看法。该项目专注于安全报告的接收、管理和审查,而非不良事件的报告。

结果

研究者和工作人员在使用各个申办方门户时所确定的首要挑战是要记住多个复杂的个人密码才能访问每个站点。此外,由于站点速度慢或与特定操作系统或软件相关的困难,某些任务很耗时(例如下载报告)。为了改善用户体验,受访者建议门户应独立于浏览器和操作系统运行,具有直观的界面且易于导航,并纳入额外功能,以便用户能够筛选、搜索和批量处理安全报告。

结论

结果表明,用于共享加速IND安全信息的理想系统是通过所有申办方都使用的中央门户。在这可行之前,电子报告门户至少应具备一致的功能。CTTI已发布相关建议以提高电子门户的质量和使用。

相似文献

4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验